Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Antiangiogenic compounds: well-established drugs versus emerging natural molecules — A. Marisa Ribeiro (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Antiangiogenic compounds: well-established drugs versus emerging natural molecules
Shared by
Isabel Cristina Fernandes Rodrigues Ferreira
Antiangiogenic compounds: well-established drugs versus emerging natural molecules
Article
2017
en
Authors
+2 more
AR
A. Marisa Ribeiro
RA
Rui M.V. Abreu
MD
Madalena M. Dias
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2008
Emerging antiviral drugs
De Clercq Erik
Article
2005
Emerging anti-HIV drugs
De Clercq Erik
Article
2005
Emerging drugs for diabetic nephropathy
Simona Bruno
,
Dario Cattaneo
,
Norberto Perico
,
Giuseppe Remuzzi
Article
2011
Emerging drugs for Waldenström's macroglobulinemia
Efstathios Kastritis
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2023
RETRACTED: Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms
Md. Mominur Rahman
,
Md. Rezaul Islam
,
Shopnil Akash
,
Md Emon Hossain
,
Afroza Alam Tumpa
,
Galib Muhammad Abrar Ishtiaque
,
Limon Ahmed
,
Abdur Rauf
,
Anees Ahmed Khalil
,
Waleed Al Abdulmonem
,
Jesus Simal Gandara
Discussion(0)
No comments yet. Be the first to comment.